Financials
- Market Capitalization 1.51 B
- Employee 159
- Founded 1996
- CEO N/A
- Website www.inva.com
- Headquarter Delaware, United States
- FIGI BBG000CG9XT7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
5.22
Relación precio/flujo de caja
4.2
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2171 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.32 USD | -1.89% | -4.91% | +2.09% | +7.22% | 1.52 B USD | ||
| 2173 | LBRX LB Pharmaceuticals Inc - Common Stock | 46.71 USD | -2.14% | -3.85% | +14.65% | +145.84% | 1.51 B USD | ||
| 2186 | BCAX Bicara Therapeutics Inc. - Common Stock | 22.82 USD | -2.60% | -3.26% | -15.01% | +58.03% | 1.51 B USD | ||
| 2191 | ABSI Absci Corporation - Common Stock | 8.74 USD | +0.34% | -1.47% | +13.51% | +271.91% | 1.50 B USD |